Commerce Bank’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Commerce Bank’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-6,000	Closed	-$612K	–	1188
2023 Q2	$612K	Buy	+6,000	New	+$568K	﹤0.01%	737

Other funds holding RETA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Commerce Bank's RETA Position: Q3 2023 in Review

Commerce Bank sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 6,000 shares — an estimated $612K sold.

Commerce Bank first reported a position in RETA in Q2 2023 and held it in 1 quarter. The position peaked at $612K in Q2 2023. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.

Commerce Bank reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Commerce Bank sold 6,000 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $612K.
Commerce Bank first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q2 2023 and held it in 1 quarter.
Commerce Bank's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $612K in Q2 2023.
2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.

Based on Commerce Bank's 13F filing for Q3 2023, filed 14 Nov 2023.